Steris (STE): Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase $1K–$15K
Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase of Steris in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 26 days
- Disclosure lag
- Traded
- May 13, 2026
- Disclosed
- Jun 8, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 16, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 31, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 31, 2026, STERIS plc (the “Company”) and Michael J. Tokich, the Company’s former Chief Financial Officer, entered into an amendment (the “Amendment”) to the Transition Agreement, dated August 5, 2025, between the Company and Mr. Tokich (the “Agreement”).”
- Apr 8, 2026FDAFDA device clearance: SYSTEM 1E Liquid Chemical Sterilant Processing System, Model P6700; SYSTEM 1 endo Liquid Chemical Sterilant Processing System, Model P6900
- Apr 8, 2026FDAFDA device clearance: Celerity 5 HP Biological Indicator (LCB052)
- Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.0%
- Apr 29, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- Apr 30, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- May 1, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On May 1, 2026, Richard C. Breeden notified STERIS plc (the “Company”) that he will not stand for reelection to the Board of Directors (the “Board”) at the Company’s 2026 Annual General Meeting of Shareholders.”
- May 1, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- May 7, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 31, 2026, Pierre Boulud was appointed to serve on the Audit Committee of the Board and the Compliance and Technology Committee of the Board.”
- May 11, 2026Company filing · Form 8-K · ResultsReported its results
- May 11, 2026Congress · 1 personMembers of Congress: 2 purchases
- May 12, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.1%
- May 13, 2026 · this disclosureCongressDisclosed purchase of STE — reported range $1,001 - $15,000
What came next
- May 15, 2026FDARecall: HarmonyAIR A-Series Surgical Lighting System
- May 15, 2026FDARecall: HarmonyAIR A-Series Surgical Lighting System
- May 15, 2026FDARecall: ALYON Surgical Lighting System
- Jun 2, 2026InsiderDirector sold ~$310K of STE shares in the open market
- Jun 4, 2026InsiderCEO sold ~$656K of STE shares in the open market
- Jun 5, 2026InsiderCEO sold ~$291K of STE shares in the open market
- Jun 15, 2026InsiderOfficer sold ~$297K of STE shares in the open market
- Jun 24, 2026FDAFDA device clearance: AMSCO 700 Steam Sterilizer
- Jul 13, 2026CongressDisclosed sale of STE — reported range $1,001 - $15,000
- Jul 24, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
- Jul 27, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
- Jul 29, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
- Jul 31, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
- Aug 5, 2026Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results“On August 5, 2026, the Company announced a targeted consolidation plan (the “Consolidation Plan”) to consolidate existing manufacturing and distribution for formulated chemistries to a new Center of Excellence in North Carolina.”
- Aug 12, 2026InsiderDirector sold ~$957K of STE shares in the open market
- Aug 25, 2026CongressDisclosed sale of STE — reported range $100,001 - $250,000
- Aug 31, 2026FDARecall: VERIFY Dual Species Self-Contained Biological Indicator Model/Catalog Number: S3060
- Aug 31, 2026FDARecall: VERIFY Biological/Integrator Challenge Pack Model/Catalog Number: LCB007
- Aug 31, 2026FDARecall: VERIFY Dual Species Self-Contained Biological Indicator Model/Catalog Number: S3061
- Aug 31, 2026FDARecall: VERIFY Biological Steam Test Pack Model/Catalog Number: S3069
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Steris
For Steris, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 3 Congress trade reports dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STE page.
Other recent filings by Rep. Gilbert Ray Cisneros Jr. (CA31)
- House Clerk periodic transaction report at Wells Fargo (WFC)Nov 10, 2026
- House Clerk periodic transaction report at Alliant Energy (LNT)Nov 10, 2026
- House Clerk periodic transaction report at Argenx (ARGX)Nov 10, 2026
- House Clerk periodic transaction report at Argenx (ARGX)Nov 10, 2026
- House Clerk periodic transaction report at Lumentum (LITE)Nov 10, 2026
The full history of Rep. Gilbert Ray Cisneros Jr. (CA31) is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded Steris (STE) stock, and how much?
Rep. Gilbert Ray Cisneros Jr. (CA31) disclosed a purchase of Steris in the $1K–$15K range. Reported range, not an exact amount.
When did it happen, and when was it made public?
Traded: May 13, 2026. Disclosed: Jun 8, 2026. That is 26 days between the two dates.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Steris recently?
For Steris, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 3 Congress trade reports dated in the last 90 days. They are listed on the STE page.
Does this mean STE stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Steris
- SEC Form 4Nov 17, 2026
- SEC Form 144Nov 13, 2026
- SEC Form 144Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 12, 2026
Everything OQRO holds on this company is on its STE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
